BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26781446)

  • 1. Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma.
    Shang C; Guo Y; Zhang H; Xue YX
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):507-13. PubMed ID: 26781446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma.
    Zhang H; Guo Y; Song Y; Shang C
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):49-55. PubMed ID: 27878359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer.
    Shang C; Guo Y; Zhang J; Huang B
    Cancer Chemother Pharmacol; 2016 May; 77(5):1061-7. PubMed ID: 27056384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells.
    Heubach J; Monsior J; Deenen R; Niegisch G; Szarvas T; Niedworok C; Schulz WA; Hoffmann MJ
    Mol Cancer; 2015 May; 14():108. PubMed ID: 25994132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer.
    Li Q; Li C; Chen J; Liu P; Cui Y; Zhou X; Li H; Zu X
    Urol Oncol; 2018 Jun; 36(6):310.e15-310.e22. PubMed ID: 29605462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells.
    Tao J; Lu Q; Wu D; Li P; Xu B; Qing W; Wang M; Zhang Z; Zhang W
    Oncol Rep; 2011 Jun; 25(6):1721-9. PubMed ID: 21468550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of MDR-1 gene in transitional cell carcinoma and its correlation with chemotherapy response.
    Pu YS; Tsai TC; Cheng AL; Tsai CY; Tseng NF; Su IJ; Hsieh CY; Lai MK
    J Urol; 1996 Jul; 156(1):271-5. PubMed ID: 8648821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer.
    He A; Liu Y; Chen Z; Li J; Chen M; Liu L; Liao X; Lv Z; Zhan Y; Zhuang C; Lin J; Huang W; Mei H
    J Exp Clin Cancer Res; 2016 Aug; 35(1):125. PubMed ID: 27514530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway.
    Ping SY; Wu CL; Yu DS
    Urol Oncol; 2012 Sep; 30(5):652-9. PubMed ID: 20884251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence.
    Zhang S; Zhong G; He W; Yu H; Huang J; Lin T
    J Urol; 2016 Oct; 196(4):1270-8. PubMed ID: 27267320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of the long noncoding RNA HOTAIR predicts recurrence in stage Ta/T1 bladder cancer.
    Yan TH; Lu SW; Huang YQ; Que GB; Chen JH; Chen YP; Zhang HB; Liang XL; Jiang JH
    Tumour Biol; 2014 Oct; 35(10):10249-57. PubMed ID: 25030736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro.
    Bilim V; Kasahara T; Hara N; Takahashi K; Tomita Y
    Int J Cancer; 2003 Jan; 103(1):29-37. PubMed ID: 12455050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
    Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W
    J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bcl-2 and bcl-X in bladder cancer.
    Kirsh EJ; Baunoch DA; Stadler WM
    J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
    Chen T; Xie W; Xie L; Sun Y; Zhang Y; Shen Z; Sha N; Xu H; Wu Z; Hu H; Wu C
    Biochem Biophys Res Commun; 2015 Dec; 468(4):666-70. PubMed ID: 26551459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma.
    Yan Y; Han J; Li Z; Yang H; Sui Y; Wang M
    Mol Med Rep; 2016 Jun; 13(6):5125-31. PubMed ID: 27122348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro.
    Smolensky D; Rathore K; Cekanova M
    BMC Cancer; 2015 Nov; 15():927. PubMed ID: 26597249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
    Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.